Module I: Peptides Certification

February 25, 2022 to February 27, 2022

Peptide therapies are increasingly playing a significant role in disease state management, performance health and anti-aging strategies. In clinical practices across the globe, peptide therapies are being used to care for cancer, infectious diseases, metabolic disorders, injuries, aesthetic medicine and much more.

The Peptide Therapy Certification program presented in 2 modules, highlights this most relevant and applicable therapy in medicine. Participants can expect to gain extensive knowledge in legal considerations, strength of evidence and clinical applications to utilize on Monday morning.

Featuring world-class clinicians and researchers, the modules will allow you to further your knowledge in the emerging field of peptides and regenerative medicine and adopting this modality into your clinical practices.

Target Audience

This course is designed for physicians (internal medicine, family medicine, endocrinologists, general medicine, and OB-GYN), pharmacists, physician assistants, nurses, nurse practitioners, and other healthcare professionals interested in learning about the advancements of preventative and anti-aging medicine.

Learning Objectives

  • Understand the legal landscape of peptides and the FDA guidance on peptides as well as compounding laws.
  • Discuss the application and dosage guidelines for peptides in a variety of conditions and situations.
  • Synthesize and apply auxiliary nutrients and diet as it relates to successful protocol planning to augment clinical efficacy of peptides.
  • Examine the role of SARMS and their therapeutic application.
  • Apply the TRIAD’s model to personalize assessment and treatment plans to optimize peptide therapy.
  • Apply peptides in aesthetic medicine.
  • Learn the application of peptides for repair and recovery in preparation of surgical procedures, injury and repair.
  • Utilize peptides for weight management and body composition.
  • Incorporate peptides as an additional tool in immune modulation protocols.
  • Examine the role of peptides in Anti-Aging medicine including senescence, senolytics and Brain Optimization.
Course summary
Available credit: 
  • 24.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 24.00 Completion
Course opens: 
02/25/2022
Course expires: 
02/28/2023
Event starts: 
02/25/2022 - 7:30am EST
Event ends: 
02/27/2022 - 5:00pm EST
Rating: 
0
Disclosure Statements
 
In accordance with The Standards for Integrity and Independence, GW requires all planners, faculty, and others in control of educational content to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months. Ineligible companies are defined as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the accredited CE Activity.  An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
No Relevant Financial Relationships
 
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following planners, faculty, staff, and others in control of educational content have no relevant financial relationships with ineligible companies.
 
Activity Director/Reviewer
  • Andrew Heyman, MD
 
Faculty
 
  • James LaValle
  • Melissa Stefko
  • Anthony Campbell
  • Kent Holtorf
  • Kathleen O’Neil-Smith
  • Sheldon Jordan
  • Suzanne Ferree Turner
 
 
Staff
 
  • Leticia Hall
  • Naomi Loughlin
  • Sheena King
  • Tiffany Duke
 
 
Disclosure of Relevant Financial Relationships
 
Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following planners, faculty, and others in control of educational content have relevant financial relationships with ineligible companies.
 
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
 
All relevant financial relationships have been mitigated prior to the individual assuming their role in the activity.
 
  • Gordon Crozier, faculty for this educational event, has received stock options from Biotech Nutritionals

Available Credit

  • 24.00 AMA PRA Category 1 Credit™
    The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
  • 24.00 Completion
Please login or register to take this course.